The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the...
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
A quick rundown of the highlights so far, and what’s still left to look forward to.
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also...
The event brought together expert medical and scientific voices and powerful patient perspectives.
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of...
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front...
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we...
What was once hailed as a historic victory has become a ‘national failure’, campaigners say.
We unpack the science behind the ECS and its significance in a range of chronic conditions.
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing...
